Literature DB >> 22236870

Blastic plasmacytoid dendritic cell neoplasm without cutaneous lesion at presentation: case report and literature review.

Huijie Wang1, Junning Cao, Xiaonan Hong.   

Abstract

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and highly aggressive hematological malignancy derived from precursors of plasmacytoid dendritic cells. This disease typically presents with cutaneous involvement as the first manifestation, with subsequent or simultaneous spread to bone marrow and peripheral blood. It is exceedingly rare to diagnose BPDCN without a cutaneous lesion. Here, we report a 21-year-old male who was diagnosed with BPDCN in the absence of cutaneous symptoms. Clinically, left inguinal nodules were noticed for 4 months. The diagnosis of BPDCN was established based on histological and immunohistochemical study of a lymph node biopsy. The patient was classified as stage IVA with bone marrow involvement and underwent three cycles of hyper-CVAD alternating with high-dose methotrexate and cytarabine. A complete response was established after one cycle; however, the patient relapsed with disseminated cutaneous lesions and bone marrow involvement following a response duration of 10 months. This case is significant for BPDCN presenting with lymph node and bone marrow involvement in the absence of characteristic cutaneous manifestations.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22236870     DOI: 10.1159/000334703

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  8 in total

1.  Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.

Authors:  Ming Sheng Lim; Karla Lemmert; Anoop Enjeti
Journal:  BMJ Case Rep       Date:  2016-01-20

2.  Blastic plasmacytoid dendritic cell neoplasm: skin and bone marrow infiltration of three cases and the review of the literature.

Authors:  Figen Atalay; Gülşen Tükenmez Demirci; Dilek Bayramgürler; Elif Birtaş Ateşoğlu; Semsi Yıldız
Journal:  Indian J Hematol Blood Transfus       Date:  2014-10-14       Impact factor: 0.900

Review 3.  Treatment of blastic plasmacytoid dendritic cell neoplasm.

Authors:  Jill M Sullivan; David A Rizzieri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

4.  Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation: an Italian multicenter study.

Authors:  Livio Pagano; Caterina Giovanna Valentini; Alessandro Pulsoni; Simona Fisogni; Paola Carluccio; Francesco Mannelli; Monia Lunghi; Gianmatteo Pica; Francesco Onida; Chiara Cattaneo; Pier Paolo Piccaluga; Eros Di Bona; Elisabetta Todisco; Pellegrino Musto; Antonio Spadea; Alfonso D'Arco; Stefano Pileri; Giuseppe Leone; Sergio Amadori; Fabio Facchetti
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

5.  A rare case of acute leukemic presentation of blastic plasmacytoid dendritic cell neoplasm without cutaneous lesions.

Authors:  Shinae Yu; Min-Jung Kwon; Kyungeun Kim; Dong-Hoe Koo; Hee-Yeon Woo; Hyosoon Park
Journal:  Ann Lab Med       Date:  2014-02-13       Impact factor: 3.464

6.  Blastic plasmocitoid dendritic cell neoplasm with leukemic spread: a GIMEMA survey.

Authors:  Caterina Giovanna Valentini; Alfonso Piciocchi; Fabio Facchetti; Fabio Guolo; Alessandro Pulsoni; Marco Vignetti; Livio Pagano
Journal:  Blood Adv       Date:  2021-12-28

Review 7.  Blastic Plasmacytoid Dendritic Cell Neoplasm: Progress in Cell Origin, Molecular Biology, Diagnostic Criteria and Therapeutic Approaches.

Authors:  Wei Cheng; Tian-Tian Yu; Ai-Ping Tang; Ken He Young; Li Yu
Journal:  Curr Med Sci       Date:  2021-07-03

8.  Pathology quiz case: Plasmacytoid dendritic cell neoplasm.

Authors:  Quinn A Dunlap; Kristine E Day; Samuel G Borak; Bradford A Woodworth
Journal:  Allergy Rhinol (Providence)       Date:  2014-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.